BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34705053)

  • 1. Metabolic regulation of RA macrophages is distinct from RA fibroblasts and blockade of glycolysis alleviates inflammatory phenotype in both cell types.
    Umar S; Palasiewicz K; Volin MV; Romay B; Rahat R; Tetali C; Arami S; Guma M; Ascoli C; Sweiss N; Zomorrodi RK; O'Neill LAJ; Shahrara S
    Cell Mol Life Sci; 2021 Dec; 78(23):7693-7707. PubMed ID: 34705053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IRAK4 inhibitor mitigates joint inflammation by rebalancing metabolism malfunction in RA macrophages and fibroblasts.
    Umar S; Palasiewicz K; Volin MV; Zanotti B; Al-Awqati M; Sweiss N; Shahrara S
    Life Sci; 2021 Dec; 287():120114. PubMed ID: 34732329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic reprogramming of macrophages instigates CCL21-induced arthritis.
    Van Raemdonck K; Umar S; Palasiewicz K; Meyer A; Volin MV; Chang HJ; Al-Awqati M; Zomorrodi RK; Shahrara S
    Immunol Cell Biol; 2022 Feb; 100(2):127-135. PubMed ID: 34779007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tofacitinib therapy intercepts macrophage metabolic reprogramming instigated by SARS-CoV-2 Spike protein.
    Palasiewicz K; Umar S; Romay B; Zomorrodi RK; Shahrara S
    Eur J Immunol; 2021 Sep; 51(9):2330-2340. PubMed ID: 34107055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IRAK4 inhibition: a promising strategy for treating RA joint inflammation and bone erosion.
    Umar S; Palasiewicz K; Van Raemdonck K; Volin MV; Romay B; Amin MA; Zomorrodi RK; Arami S; Gonzalez M; Rao V; Zanotti B; Fox DA; Sweiss N; Shahrara S
    Cell Mol Immunol; 2021 Sep; 18(9):2199-2210. PubMed ID: 32415262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The glycolysis inhibitor 2-deoxyglucose ameliorates adjuvant-induced arthritis by regulating macrophage polarization in an AMPK-dependent manner.
    Cai W; Cheng J; Zong S; Yu Y; Wang Y; Song Y; He R; Yuan S; Chen T; Hu M; Pan Y; Ma R; Liu H; Wei F
    Mol Immunol; 2021 Dec; 140():186-195. PubMed ID: 34735867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of niclosamide on inflammation and migration of fibroblast-like synoviocytes from patients with rheumatoid arthritis.
    Liang L; Huang M; Xiao Y; Zen S; Lao M; Zou Y; Shi M; Yang X; Xu H
    Inflamm Res; 2015 Apr; 64(3-4):225-33. PubMed ID: 25708600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic reprogramming by Syntenin-1 directs RA FLS and endothelial cell-mediated inflammation and angiogenesis.
    Meyer A; Zack SR; Nijim W; Burgos A; Patel V; Zanotti B; Volin MV; Amin MA; Lewis MJ; Pitzalis C; Arami S; Karam JA; Sweiss NJ; Shahrara S
    Cell Mol Immunol; 2024 Jan; 21(1):33-46. PubMed ID: 38105293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-34 Reprograms Glycolytic and Osteoclastic Rheumatoid Arthritis Macrophages via Syndecan 1 and Macrophage Colony-Stimulating Factor Receptor.
    Van Raemdonck K; Umar S; Palasiewicz K; Volin MV; Elshabrawy HA; Romay B; Tetali C; Ahmed A; Amin MA; Zomorrodi RK; Sweiss N; Shahrara S
    Arthritis Rheumatol; 2021 Nov; 73(11):2003-2014. PubMed ID: 33982895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL25 and CCR9 is a unique pathway that potentiates pannus formation by remodeling RA macrophages into mature osteoclasts.
    Umar S; Palasiewicz K; Van Raemdonck K; Volin MV; Romay B; Ahmad I; Tetali C; Sweiss N; Amin MA; Zomorrodi RK; Shahrara S
    Eur J Immunol; 2021 Apr; 51(4):903-914. PubMed ID: 33347617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting bioenergetics prevents CD4 T cell-mediated activation of synovial fibroblasts in rheumatoid arthritis.
    Petrasca A; Phelan JJ; Ansboro S; Veale DJ; Fearon U; Fletcher JM
    Rheumatology (Oxford); 2020 Oct; 59(10):2816-2828. PubMed ID: 32047926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCL21/CCR7 signaling in macrophages promotes joint inflammation and Th17-mediated osteoclast formation in rheumatoid arthritis.
    Van Raemdonck K; Umar S; Palasiewicz K; Volkov S; Volin MV; Arami S; Chang HJ; Zanotti B; Sweiss N; Shahrara S
    Cell Mol Life Sci; 2020 Apr; 77(7):1387-1399. PubMed ID: 31342120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage polarization in rheumatoid arthritis: signaling pathways, metabolic reprogramming, and crosstalk with synovial fibroblasts.
    Zheng Y; Wei K; Jiang P; Zhao J; Shan Y; Shi Y; Zhao F; Chang C; Li Y; Zhou M; Lv X; Guo S; He D
    Front Immunol; 2024; 15():1394108. PubMed ID: 38799455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical Role of Glucose Metabolism in Rheumatoid Arthritis Fibroblast-like Synoviocytes.
    Garcia-Carbonell R; Divakaruni AS; Lodi A; Vicente-Suarez I; Saha A; Cheroutre H; Boss GR; Tiziani S; Murphy AN; Guma M
    Arthritis Rheumatol; 2016 Jul; 68(7):1614-26. PubMed ID: 26815411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon Gamma Induces Reversible Metabolic Reprogramming of M1 Macrophages to Sustain Cell Viability and Pro-Inflammatory Activity.
    Wang F; Zhang S; Jeon R; Vuckovic I; Jiang X; Lerman A; Folmes CD; Dzeja PD; Herrmann J
    EBioMedicine; 2018 Apr; 30():303-316. PubMed ID: 29463472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyr61 induces IL-6 production by fibroblast-like synoviocytes promoting Th17 differentiation in rheumatoid arthritis.
    Lin J; Zhou Z; Huo R; Xiao L; Ouyang G; Wang L; Sun Y; Shen B; Li D; Li N
    J Immunol; 2012 Jun; 188(11):5776-84. PubMed ID: 22547695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype.
    Freemerman AJ; Johnson AR; Sacks GN; Milner JJ; Kirk EL; Troester MA; Macintyre AN; Goraksha-Hicks P; Rathmell JC; Makowski L
    J Biol Chem; 2014 Mar; 289(11):7884-96. PubMed ID: 24492615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyr61 is involved in neutrophil infiltration in joints by inducing IL-8 production by fibroblast-like synoviocytes in rheumatoid arthritis.
    Zhu X; Xiao L; Huo R; Zhang J; Lin J; Xie J; Sun S; He Y; Sun Y; Zhou Z; Shen B; Li N
    Arthritis Res Ther; 2013; 15(6):R187. PubMed ID: 24517278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syntenin-1-mediated arthritogenicity is advanced by reprogramming RA metabolic macrophages and Th1 cells.
    Meyer A; Sienes RE; Nijim W; Zanotti B; Umar S; Volin MV; Van Raemdonck K; Lewis M; Pitzalis C; Arami S; Al-Awqati M; Chang HJ; Jetanalin P; Schett G; Sweiss N; Shahrara S
    Ann Rheum Dis; 2023 Apr; 82(4):483-495. PubMed ID: 36593091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyphyllin I Ameliorates Collagen-Induced Arthritis by Suppressing the Inflammation Response in Macrophages Through the NF-κB Pathway.
    Wang Q; Zhou X; Zhao Y; Xiao J; Lu Y; Shi Q; Wang Y; Wang H; Liang Q
    Front Immunol; 2018; 9():2091. PubMed ID: 30319603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.